Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Texas Health Presbyterian Hospital Dallas located at 8200 Walnut Hill Lane, Dallas, TX, 75231 & includes data from NPIs 1255412789, 1245311695, 1396779948
Dexur analyzed Q4 2017 (October to December 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Texas Health Presbyterian Hospital Dallas compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,060 | 1,995 | ||||||||||
| Surgical | 711 | 696 | ||||||||||
| Non Surgical | 1,349 | 1,299 | ||||||||||
| Orthopedics | 427 | 425 | ||||||||||
| Cardiovascular | 417 | 400 | ||||||||||
| General Medicine | 221 | 206 | ||||||||||
| Neurology | 194 | 187 | ||||||||||
| General Surgery | 159 | 153 | ||||||||||
| Pulmonology | 156 | 151 | ||||||||||
| Gastroenterology & Endocrinology | 151 | 148 | ||||||||||
| Urology | 110 | 108 | ||||||||||
| Psychiatry & Mental Disorders | 82 | 78 | ||||||||||
| Oncology & Hematology | 52 | 50 | ||||||||||
| Spine | 37 | 37 | ||||||||||
| Colorectal | 17 | 16 | ||||||||||
| Obstetrics & Gynecology | 15 | 15 | ||||||||||
| Dermatology | 11 | 11 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 11 | NA |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
| DRG 493: LOWER EXTREMITY AND HUMERUS PROCEDURES EXCEPT HIP, FOOT AND FEMUR WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hypertension | ||||||||||||
| DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| Coronary Bypass | ||||||||||||
| Peripheral Vascular Disorders |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| Seizures | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Nonspecific Cerebrovascular Disorders |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Major Chest Procedures |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Cholecystectomy | ||||||||||||
| Diabetes |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Oct 2017 to Dec 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |